Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Stelara 45mg/0.5ml inj pre-filled syringes
1305030D0BBABAB
|
Stelara | Ustekinumab | Skin | 4 |
|
Stelara 90mg/1ml solution for injection pre-filled syringes
1305030D0BBACAC
|
Stelara | Ustekinumab | Skin | 1 |
|
Ustekinumab 90mg/1ml inj pre-filled syringes
1305030D0AAACAC
|
Ustekinumab | Ustekinumab | Skin | 1 |
|
Imuldosa 130mg/26ml concentrate for inf vials
0105030B0BHAAAA
|
Imuldosa | Ustekinumab | Gastro-Intestinal System | No data available |
|
Imuldosa 45mg/0.5ml inj pre-filled syringes
1305030D0BHAAAB
|
Imuldosa | Ustekinumab | Skin | No data available |
|
Imuldosa 90mg/1ml solution for injection pre-filled syringes
1305030D0BHABAC
|
Imuldosa | Ustekinumab | Skin | No data available |
|
Otulfi 130mg/26ml concentrate for inf vials
0105030B0BGAAAA
|
Otulfi | Ustekinumab | Gastro-Intestinal System | No data available |
|
Otulfi 45mg/0.5ml solution for injection pre-filled syringes
1305030D0BGAAAB
|
Otulfi | Ustekinumab | Skin | No data available |
|
Otulfi 90mg/1ml solution for injection pre-filled syringes
1305030D0BGABAC
|
Otulfi | Ustekinumab | Skin | No data available |
|
Pyzchiva 130mg/26ml concentrate for inf vials
0105030B0BCAAAA
|
Pyzchiva | Ustekinumab | Gastro-Intestinal System | No data available |
|
Pyzchiva 45mg/0.5ml inj pre-filled syringes
1305030D0BCACAB
|
Pyzchiva | Ustekinumab | Skin | No data available |
|
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
1305030D0BCABAC
|
Pyzchiva | Ustekinumab | Skin | No data available |
|
Stelara 130mg/26ml concentrate for inf vials
0105030B0BBAAAA
|
Stelara | Ustekinumab | Gastro-Intestinal System | No data available |
|
Stelara 45mg/0.5ml solution for injection vials
1305030D0BBAAAA
|
Stelara | Ustekinumab | Skin | No data available |
|
Steqeyma 130mg/26ml concentrate for inf vials
0105030B0BEAAAA
|
Steqeyma | Ustekinumab | Gastro-Intestinal System | No data available |
|
Steqeyma 45mg/0.5ml inj pre-filled syringes
1305030D0BFAAAB
|
Steqeyma | Ustekinumab | Skin | No data available |
|
Steqeyma 90mg/1ml solution for injection pre-filled syringes
1305030D0BFABAC
|
Steqeyma | Ustekinumab | Skin | No data available |
|
Ustekinumab 130mg/26ml solution for infusion vials
0105030B0AAAAAA
|
Ustekinumab | Ustekinumab | Gastro-Intestinal System | No data available |
|
Ustekinumab 45mg/0.5ml inj pre-filled syringes
1305030D0AAABAB
|
Ustekinumab | Ustekinumab | Skin | No data available |
|
Ustekinumab 45mg/0.5ml solution for injection vials
1305030D0AAAAAA
|
Ustekinumab | Ustekinumab | Skin | No data available |
|
Uzpruvo 130mg/26ml concentrate for solution for inf vials
0105030B0BFAAAA
|
Uzpruvo | Ustekinumab | Gastro-Intestinal System | No data available |
|
Uzpruvo 45mg/0.5ml inj pre-filled syringes
1305030D0BDAAAB
|
Uzpruvo | Ustekinumab | Skin | No data available |
|
Uzpruvo 90mg/1ml solution for injection pre-filled syringes
1305030D0BDABAC
|
Uzpruvo | Ustekinumab | Skin | No data available |
|
Wezenla 130mg/26ml concentrate for inf vials
0105030B0BDAAAA
|
Wezenla | Ustekinumab | Gastro-Intestinal System | No data available |
|
Wezenla 45mg/0.5ml inj pre-filled syringes
1305030D0BEABAB
|
Wezenla | Ustekinumab | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.